IQVIA™ Real-World Insights Bibliography

High Prevalence of Comorbidities and Contraindicated Medications in Hepatitis C Patients in Japan
Author(s): Tsutsumi, T., Kruger, E., Tan, S. C., Yotsuyanagi, H.
Affiliations(s): QuintilesIMS Singapore
Publication(s):  Journal of Viral Hepatitis
Document Type(s): Article,
Countries: Singapore,
C:
Y:
Infectious disease,
2017
  L:
A:
English
Budget impact,
  Add to report
 
 
Cost-effectiveness of switching from biphasic human insulin (BHI) to biphasic insulin aspart 30 (BIAsp-30) in type 2 diabetes patients with suboptimal glycaemic control in Singapore
Author(s): Goh SY1, Tan SC2, Lim LC3, Chua B4, Hunt B5
Affiliations(s): 1 Department of Endocrinology, Singapore General Hospital, Singapore 2 Health Economics & Outcomes Research, IMS Health Asia Pacific, Singapore 3 Department of Medicine, Alexandra Hospital, Singapore 4 Department of Vascular Surgery, Singapore General Hospital, Singapore 5 Ossian Health Economics and Communications, Switzerland
Publication(s):  Journal of Diabetology, February 2015; 1:2
Document Type(s): Online article,
Countries: Singapore,
C:
Y:
Diabetes,
2015
  L:
A:
English
Cost effectiveness,
  Add to report
 
 
Budget Impact analysis of wider adoption of Biphasic Insulin Aspart (Biasp) in the treatment of type 2 Diabetes Mellitus (T2dm): A perspective of patients treated by public providers in Singapore
Author(s): Tan SC1, Matzen P2, Khoo SP2
Affiliations(s): 1 IMS Asia Pacific, Singapore 2 Novo Nordisk Pharma Malaysia, Kuala Lumpur, Malaysia 3 Novo Nordisk Pharma Singapore, Singapore
Publication(s):  ISPOR 6th Asia-Pacific Conference, Beijing, China, 6-9 September, 2014
Document Type(s): Poster,
Countries: Singapore,
C:
Y:
Diabetes,
2014
  L:
A:
English
Budget impact,
  Add to report
 
 
Drug access through sharing public and individual responsibilities in the public healthcare system of Singapore
Author(s): Tan SC1, Low PY2, Chia MX2
Affiliations(s): 1IMS Asia Pacific, Singapore, Singapore, 2IMS Health Asia, Singapore, Singapore
Publication(s):  ISPOR 6th Asia-Pacific Conference, Beijing, China, 6-9 September, 2014
Document Type(s): Poster,
Countries: Singapore,
Click here for the abstract
C:
Y:
Health policy,
2014
  L:
A:
English
Review,
  Add to report
 
 
The cost-effectiveness of travoprost preserved with polyquad® in newly treated open-angle glaucoma patients in 7 Asian countries.
Author(s): Gerlier L1, Lamotte M1, Caputo J2, Tan R3
Affiliations(s): 1 IMS Health Consulting EMEA, Vilvoorde, Belgium 2 IMS Health Consulting Asia-Pacific, Singapore 3 ALCON, Asia-Pacific, Singapore
Publication(s):  5th ISPOR Asia-Pacific Conference, 2012, September 2-4, Taipei, Taiwan
Document Type(s): Abstract, Poster,
Countries: India, Malaysia, Singapore, South Korea, Thailand,
C:
Y:
Ophthalmology,
2012
  L:
A:
English
Cost effectiveness,
  Add to report
 
 
Medical resource use and associated costs in open-angle glaucoma in 10 Asia-pacific countries.
Author(s): Gerlier L1, Lamotte M1, Caputo J2, Tan R3
Affiliations(s): 1 IMS Health Consulting EMEA, Vilvoorde, Belgium 2 IMS Health Consulting Asia-Pacific, Singapore 3 ALCON, Asia-Pacific, Singapore
Publication(s):  5th ISPOR Asia-Pacific Conference, 2012, September 2-4, Taipei, Taiwan
Document Type(s): Abstract, Poster,
Countries: Australia, China, Hong Kong, India, Malaysia, New Zealand, Singapore, South Korea, Taiwan, Thailand,
C:
Y:
Ophthalmology,
2012
  L:
A:
English
Burden of illness,
  Add to report
 
 
Asthma control and its direct healthcare costs: findings using a derived Asthma Control Test (ACT) score in eight Asia-Pacific areas.
Author(s): Lai CKW1 Kuo S-H2 de Guia T3 Lloyd A4, Williams AE5, Spencer MD5
Affiliations(s): 1 Dept of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong 2 National Taiwan University Hospital, Taipei, Taiwan 3 Philippine Heart Centre, Quezon City, The Philippines 4 Fourth Hurdle Consulting Ltd, London, UK 5 GlaxoSmithKine R&D, Greenford, UK
Publication(s):  European Respiratory Review 2006; 15:(98): 24-29
Document Type(s): Manuscript in preparation,
Countries: China, Hong Kong, Malaysia, Philippines, Singapore, Taiwan, Vietnam,
C:
Y:
Respiratory disease,
2006
  L:
A:
English
Cost of illness,
  Add to report